Skip to main content
  • ACC: Novel CIN Drug Goes to the 'Graveyard' CMX-2043 did not reduce contrast-induced nephropathy in PCI

     

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details